James B Weissman - Net Worth and Insider Trading
James B Weissman Net Worth
The estimated net worth of James B Weissman is at least $611,520 dollars as of 2024-12-28. James B Weissman is the COO & EVP of Dicerna Pharmaceuticals Inc and owns about 16,000 shares of Dicerna Pharmaceuticals Inc (DRNA) stock worth over $611,520. Details can be seen in James B Weissman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James B Weissman has not made any transactions after 2021-07-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James B Weissman
James B Weissman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James B Weissman owns 1 companies in total, including Dicerna Pharmaceuticals Inc (DRNA) .
Click here to see the complete history of James B Weissman’s form 4 insider trades.
Insider Ownership Summary of James B Weissman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DRNA | Dicerna Pharmaceuticals Inc | 2021-07-06 | Chief Operating Officer & EVP |
James B Weissman Latest Holdings Summary
James B Weissman currently owns a total of 1 stock. James B Weissman owns 16,000 shares of Dicerna Pharmaceuticals Inc (DRNA) as of July 6, 2021, with a value of $611,520.
Latest Holdings of James B Weissman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DRNA | Dicerna Pharmaceuticals Inc | 2021-07-06 | 16,000 | 38.22 | 611,520 |
Holding Weightings of James B Weissman
James B Weissman Form 4 Trading Tracker
According to the SEC Form 4 filings, James B Weissman has made a total of 16 transactions in Dicerna Pharmaceuticals Inc (DRNA) over the past 5 years, including 0 buys and 16 sells. The most-recent trade in Dicerna Pharmaceuticals Inc is the sale of 30,000 shares on July 6, 2021, which brought James B Weissman around $1 Million.
Insider Trading History of James B Weissman
- 1
James B Weissman Trading Performance
GuruFocus tracks the stock performance after each of James B Weissman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James B Weissman is 5.83%. GuruFocus also compares James B Weissman's trading performance to market benchmark return within the same time period. The performance of stocks bought by James B Weissman within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James B Weissman's insider trading performs compared to the benchmark.
Performance of James B Weissman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.83 | | | | | |
| Relative Return to S&P 500(%) | 4.28 | | | | | |
James B Weissman Ownership Network
James B Weissman Owned Company Details
What does Dicerna Pharmaceuticals Inc do?
Who are the key executives at Dicerna Pharmaceuticals Inc?
James B Weissman is the Chief Operating Officer & EVP of Dicerna Pharmaceuticals Inc. Other key executives at Dicerna Pharmaceuticals Inc include See Remarks Bob D Brown , EVP & Chief Medical Officer Shreeram Aradhye , and director & President and CEO Douglas Fambrough .
Dicerna Pharmaceuticals Inc (DRNA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Dicerna Pharmaceuticals Inc (DRNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dicerna Pharmaceuticals Inc (DRNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Dicerna Pharmaceuticals Inc (DRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dicerna Pharmaceuticals Inc Insider Transactions
James B Weissman Mailing Address
Above is the net worth, insider trading, and ownership report for James B Weissman. You might contact James B Weissman via mailing address: C/o Dicerna Pharmaceuticals, Inc. 33 Hayden Avenue Lexington Ma 02421.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
